SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001178913-22-004049
Filing Date
2022-11-15
Accepted
2022-11-15 16:03:38
Documents
1
Period of Report
2022-11-14

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 3201
  Complete submission text file 0001178913-22-004049.txt   4668
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Issuer) CIK: 0001534248 (see all company filings)

IRS No.: 813676773 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 672 PROSPECT AVE. PRINCETON NJ 08540
Business Address
Frankel Matthew Bejosa (Reporting) CIK: 0001952634 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38807 | Film No.: 221391150